 | Kiniksa Pharmaceuticals (NASDAQ:KNSA) Downgraded by BidaskClub to Hold
www.marketbeat.com - July 3 at 2:34 AM |
 | Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) EVP Thomas W. Beetham Sells 29,589 Shares
www.marketbeat.com - July 2 at 5:47 PM |
| Kiniksa Pharmaceuticals Ltd Expected to Earn Q2 2020 Earnings of ($0.50) Per Share (NASDAQ:KNSA)
www.americanbankingnews.com - July 2 at 7:45 AM |
| Kiniksa Pharmaceuticals Ltd to Post Q1 2021 Earnings of ($0.60) Per Share, Wedbush Forecasts (NASDAQ:KNSA)
www.americanbankingnews.com - July 1 at 8:36 AM |
 | Kiniksa's Heart Drug, And Other News: The Good, Bad, And Ugly Of Biopharma
seekingalpha.com - June 30 at 3:48 PM |
| Goldman Sachs Group Raises Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $33.00
www.americanbankingnews.com - June 30 at 12:02 PM |
 | Company News for Jun 30, 2020
finance.yahoo.com - June 30 at 10:47 AM |
| Zacks.com featured highlights include: eXp World, Lakeland Industries, Meridian Bioscience, Kiniksa Pharmaceuticals and iClick Interactive Asia Group
finance.yahoo.com - June 30 at 10:47 AM |
 | FDA Snubs HRTX Again, ICPT Disappoints, KNSA Hits Right Notes, Is The Writing On The Wall For VRCA?
www.nasdaq.com - June 30 at 5:47 AM |
| BofA Securities Boosts Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $40.00
www.americanbankingnews.com - June 29 at 2:30 PM |
|
| Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $40.00 at BofA Securities
www.americanbankingnews.com - June 29 at 2:30 PM |
 | Why Kiniksa's Stock Is Trading Higher Today
www.benzinga.com - June 29 at 12:40 PM |
| Kiniksa Reports Positive Results of Pericarditis-Drug Trial
finance.yahoo.com - June 29 at 12:40 PM |
| Kiniksa Pharmaceuticals (NASDAQ:KNSA) PT Raised to $38.00 at Wedbush
www.americanbankingnews.com - June 29 at 11:52 AM |
| -$0.58 Earnings Per Share Expected for Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) This Quarter
www.americanbankingnews.com - June 27 at 9:14 PM |
| Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - June 23 at 12:24 PM |
| Kiniksa Announces Lancet Rheumatology Publication of Clinical Outcomes with Mavrilimumab in COVID-19
finance.yahoo.com - June 17 at 9:06 AM |
| Consonance Capital Management reports 11% stake in Kiniksa
seekingalpha.com - June 16 at 1:52 PM |
| Insider Selling: Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) EVP Sells 13,752 Shares of Stock
www.americanbankingnews.com - June 15 at 4:16 AM |
| Zacks.com featured highlights include: SunOpta, eXp World, Calix, Kiniksa Pharmaceuticals and iClick Interactive Asia Group
finance.yahoo.com - June 12 at 12:27 PM |
| Kiniksa Provides Timing of Second Half 2020 Clinical Data Readouts
finance.yahoo.com - June 10 at 12:49 PM |
| Kiniksa Positive COVID-19 Data And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - June 10 at 7:48 AM |
| Kiniksa's mavrilimumab shows encouraging effect in COVID patients
seekingalpha.com - June 8 at 11:46 AM |
| Kiniksa Announces 28-Day Clinical Outcomes Data from Mavrilimumab Treatment Protocol in Severe COVID-19 Pneumonia and Active U.S. IND for Phase 2/3 Clinical Trial
finance.yahoo.com - June 8 at 11:46 AM |
| Kiniksa Pharmaceuticals to Present at 41st Annual Goldman Sachs Global Healthcare Conference
finance.yahoo.com - June 4 at 9:40 AM |
 | BRIEF-Kiniksa Pharmaceuticals Files For Offering Of Up To 1.6 Mln Class A Common Shares
www.reuters.com - May 22 at 1:51 PM |
| How Kiniksa Pharmaceuticals (KNSA) Stock Stands Out in a Strong Industry
finance.yahoo.com - May 22 at 1:51 PM |
 | Kiniksa Pharmaceuticals, Ltd. Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
www.marketwatch.com - May 18 at 6:13 PM |
| Kiniksa Pharmaceuticals, Ltd. Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - May 18 at 6:13 PM |
| Kiniksa Pharmaceuticals prices equity offering, Shares down 5%
seekingalpha.com - May 14 at 1:59 AM |
|
| Kiniksa Pharmaceuticals, Ltd. Announces Proposed Public Offering
finance.yahoo.com - May 13 at 8:58 PM |
 | Which way to trade Kiniksa Pharmaceuticals (NSQ:KNSA)?
uk.finance.yahoo.com - May 13 at 9:52 AM |
| Kiniksa's mavrilimumab shows positive effect in severely-ill COVID patients
seekingalpha.com - May 11 at 3:19 PM |
| Kiniksa Reports Data for Mavrilimumab in COVID-19 Pneumonia and Hyperinflammation and for Vixarelimab in Diseases Characterized by Chronic Pruritus
finance.yahoo.com - May 11 at 10:17 AM |
| Will Kiniksa Pharmaceuticals Continue to Surge Higher?
finance.yahoo.com - May 6 at 6:06 PM |
| Kiniksa Pharmaceuticals EPS beats by $0.13
seekingalpha.com - April 28 at 11:23 AM |
| Kiniksa's vixarelimab successful in lumpy skin disease
seekingalpha.com - April 22 at 1:57 PM |
| Kiniksa Announces Phase 2 Clinical Trial of Vixarelimab (KPL-716) in Prurigo Nodularis Meets Primary Efficacy Endpoint
finance.yahoo.com - April 22 at 8:57 AM |
| Kiniksa's Unexpected Play
seekingalpha.com - April 11 at 2:14 AM |
| Has Kiniksa Pharmaceuticals (KNSA) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - April 8 at 12:31 PM |
 | Vaccine for COVID-19 Health Crises "Possible" by Summer After FDA Fast-Tracks Clinical Trials
www.prnewswire.com - April 1 at 4:01 PM |
| Stock Alert: Kiniksa Pharma Gains 20%
www.nasdaq.com - March 31 at 12:16 PM |
| Kiniksa Pharma's mavrilimumab shows treatment response in COVID-19 patients; shares up 39% premarket
seekingalpha.com - March 31 at 12:16 PM |
| Kiniksa Announces Early Evidence of Treatment Response with Mavrilimumab in 6 Patients with Severe COVID-19 Pneumonia and Hyperinflammation
finance.yahoo.com - March 31 at 12:16 PM |
| Kiniksa Highlights Phase 2 Study Data Showing the...
www.benzinga.com - March 30 at 9:02 PM |
| Kiniksa Highlights Phase 2 Study Data Showing the Corticosteroid-Sparing Effect of Rilonacept in Patients with Recurrent Pericarditis at the American College of Cardiology's 69th Annual Scientific Session
finance.yahoo.com - March 30 at 9:02 PM |
| Gilead's BLA for CAR T Cell Therapy Gets FDA Acceptance
finance.yahoo.com - February 11 at 2:15 PM |
 | BRIEF-Kiniksa Pharmaceuticals says CFO Chris Heberlig, Agreed That He Will Transition To A Consulting Role With Co On March 20
www.msn.com - February 5 at 7:50 PM |
| Kiniksa Announces Pipeline Progress and Reiterates 2020 Clinical Data Readouts
finance.yahoo.com - January 13 at 1:32 PM |
| Did Hedge Funds Drop The Ball On Kiniksa Pharmaceuticals, Ltd. (KNSA) ?
finance.yahoo.com - December 16 at 8:55 AM |
